About Mitem Pharma

As no patient should be left without a solution, we have chosen to create Mitem Pharma, an agile pharmaceutical laboratory dedicated to MITMs (Medicinal products of Major Therapeutic Interest).

Mitem Pharma is constantly adapting to the patients, the environment and the evolution of the market to make MITMs accessible everywhere and at every moment of life, in particular in the fields of endocrinology, emergency cardiology and medical dermatology.

Our Team

Our team is made up of experts in medicine, medical research, pharmaceutical industry and medication, as well as experts in logistics, purchasing and management. All those expertises combined allows us to ensure the quality of our products and their accessibility for patients.

@EntreMel & vous

CLAUDE-ALAIN CUDENNEC
CO-FOUNDER & CEO

Claude-Alain CUDENNEC is a PhD graduate from the University of Nantes in developmental biology and molecular biology. After a few years in the CNRS immunology division, he created the Cancer-Immunology Research Division at the Servier Research Institute. He then created the Pierre Fabre Immunology and Biotechnology Center before taking responsibility for all of Pierre Fabre Medicaments’ R&D. Claude-Alain then turned to entrepreneurship, which led him to participate in the creation of France-Biotech and to develop several biotech companies in France and North America, including Mitem Pharma.

@EntreMel & vous

ÉRIC THIERRY
CO-FOUNDER & COO

Eric THIERRY is graduated from the Centre de Formation Professionnelle de la Pharmacie de Paris, and started his career at Servier and Sanofi. He has accumulated more than 30 years of experience as an executive in the pharmaceutical industry where he held positions in the field, marketing and sales management, then operations management at CL Innovation. From 2008 onwards, he focused his career on the global management of pharmaceutical companies in Europe (France, UK and the Netherlands). Since 2016, as co-founder of Mitem Pharma, he focuses on sales, partnerships and supply chain management.

ADRIEN SAGNOLE
CFO

Adrien SAGNOLE graduated from SKEMA Business School with a Master in Management, specializing in Corporate Finance. He has over 12 years of experience in corporate finance. Adrien began his career in 2013 at Mazars as a financial auditor. He then joined Cerba HealthCare, where he spent 9 years, first as Group Financial Controller, responsible in particular for management reporting and the financial analysis of M&A transactions. He later became Head of Financial Controlling, supporting the group in its external growth strategy. Adrien has been the CFO of MITEM Pharma since June 2025.

@EntreMel & vous

DANIEL PIGNARD
PHARMACEUTICAL AFFAIRS DIRECTOR, QUALIFIED PERSON

Daniel PIGNARD, Doctor of Pharmacy, graduated from the Faculty of Pharmacy in Lyon and holds a Master’s degree in Business Management (IAE Lyon). He has more than 25 years of experience in the pharmaceutical industry where he held operational positions as a deputy qualified person in charge of manufacturing/operating process. Daniel was responsible for the quality audit team of the SEQENS pharmaceutical group for 6 years, involved in the FDA remediation plan for API manufacturing sites (17 GMP Part 1 and Part 2 sites). He joined Mitem Pharma as Head Pharmacist & Qualified Person.

@EntreMel & vous

SOURIYA GHADDA
HEAD OF REGULATORY AFFAIRS & QUALITY ASSURANCE, DEPUTY QUALIFIED PERSON

Souriya GHADDA, Doctor of Pharmacy, graduated from the Faculty of Pharmacy in Grenoble and holds a Master’s degree in Regulatory Affairs for the Healthcare Industries (ARIS) from the University of Paris-Saclay. She began her career in the pharmaceutical industry with an apprenticeship in International Regulatory Affairs at Sanofi (Gentilly). She later held the position of Export Regulatory Affairs Division Manager at Arrow Laboratory. Today, Souriya is Head of Regulatory Affairs and Quality Assurance at Mitem Pharma. She also holds the position of Deputy Qualified Person.

French laboratory, Mitem Pharma is also present on the main European markets and worldwide through 15 countries on 3 continents